WallStreetZenWallStreetZen

NASDAQ: BIIB
Biogen Inc Stock Ownership - Who owns Biogen?

Insider buying vs selling

Have Biogen Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Priya SinghalHead of Development2024-04-0293$213.09
$19.82kSell
Nicole MurphyHead of Pharm Ops and Tech2024-04-01117$214.83
$25.14kSell
Priya SinghalHead of Development2024-02-22262$221.23
$57.96kSell
Priya SinghalHead of Development2024-02-16295$219.08
$64.63kSell
Priya SinghalHead of Development2024-02-16173$219.08
$37.90kSell
Ginger GregoryEVP Human Resources2024-02-16729$219.08
$159.71kSell
Ginger GregoryEVP Human Resources2024-02-161,535$219.08
$336.29kSell
Priya SinghalHead of Development2024-02-16108$221.49
$23.92kSell
Robin KramerChief Accounting Officer2024-02-16127$219.08
$27.82kSell
Susan H. AlexanderEVP Chief Legal Officer2024-02-16781$219.08
$171.10kSell

1 of 5

BIIB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BIIB insiders and whales buy or sell their stock.

BIIB Shareholders

What type of owners hold Biogen Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Primecap Management Co11.19%16,264,481$3.13BInstitution
Vanguard Group Inc9.91%14,407,330$2.77BInstitution
Blackrock Inc9.80%14,246,658$2.74BInstitution
State Street Corp4.78%6,945,665$1.33BInstitution
T Rowe Price Investment Management Inc3.69%5,357,326$1.03BInstitution
Wellington Management Group LLP3.66%5,324,396$1.02BInstitution
Jpmorgan Chase Co3.45%5,011,319$962.98MInstitution
Geode Capital Management LLC2.28%3,309,317$635.92MInstitution
Invesco Ltd1.25%1,814,666$348.71MInstitution
Clearbridge Investments LLC1.16%1,679,302$322.69MInstitution

1 of 3

BIIB vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BIIB87.86%2.11%Net SellingNet Selling
OGN77.39%0.19%Net SellingNet Selling
GRFS17.73%0.00%
AMRN22.86%15.41%Net SellingNet Selling
SCLX15.74%37.69%

Biogen Stock Ownership FAQ

Who owns Biogen?

Biogen (NASDAQ: BIIB) is owned by 87.86% institutional shareholders, 2.11% Biogen insiders, and 10.02% retail investors. Primecap Management Co is the largest individual Biogen shareholder, owning 16.26M shares representing 11.19% of the company. Primecap Management Co's Biogen shares are currently valued at $3.10B.

If you're new to stock investing, here's how to buy Biogen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.